Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carboprost Tromethamine (Hemabate) for Resection of Fibroids-a Pilot Study

NCT05518812 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT05518812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05518812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carboprost Tromethamine (Hemabate) for Resection of Fibroids-a Pilot Study
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Completed
Start date
July 12, 2022
Completion date
May 6, 2024
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibroid uterus, gynecologic disease, leiomyoma, uterine